X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

npj Breast Cancer

期刊標題檢索 NPJ BREAST CANC 最新評論: Peer review First reviewer(s) invited on 21 Mar 2026 It has been 3... (2026-04-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[npj Breast Cancer]您好,您是該頁面的第 17683 位訪客。

期刊簡介
期刊名稱npj Breast Cancer npj Breast Cancer
LetPub Score
7.3
50 ratings
Rate

Reputation
8.3

Influence
6.1

Speed
9.4

期刊簡稱NPJ BREAST CANCER
ISSN2374-4677
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.702.9681.690
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q110 / 346
Category: Medicine
Subcategory: Pharmacology (medical)
Q19 / 275
Category: Medicine
Subcategory: Oncology
Q141 / 415

自引率 (2023-2024)3.00%自引率趨勢
掲載範囲
npj Breast Cancer publishes original research articles, reviews, brief correspondence, meeting reports, editorial summaries and hypothesis generating observations which could be unexplained or preliminary findings from experiments, novel ideas, or the framing of new questions that need to be solved. Featured topics of the journal include imaging, immunotherapy, molecular classification of disease, mechanism-based therapies largely targeting signal transduction pathways, carcinogenesis including hereditary susceptibility and molecular epidemiology, survivorship issues including long-term toxicities of treatment and secondary neoplasm occurrence, the biophysics of cancer, mechanisms of metastasis and their perturbation, and studies of the tumor microenvironment.
官方網站http://www.nature.com/npjbcancer
在線稿件提交
開放訪問Yes
出版商Springer Nature
主題領域Medicine
出版國/地區ENGLAND
發行頻率
創刊年2015
每年文章數101每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP2690; USD3490; EUR2990; )
APC waiver:Check Notes
Other charges: No
Keywords: biophysics of cancer、metastasis、histopathology、carcinogenesis
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ142/328
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2374-4677%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 9 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【npj Breast Cancer】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    ACS Pharmacology & Translational ScienceH-index: 0

    CiteScore: 7.50
    Therapeutic Advances in Drug SafetyH-index: 0

    CiteScore: 5.30
    Infection and Drug ResistanceH-index: 27

    CiteScore: 5.50
    Translational and Clinical PharmacologyH-index: 0

    CiteScore: 2.00
    Medizinische Monatsschrift fur PharmazeutenH-index: 0

    CiteScore: 0.00
    Adverse Drug Reaction BulletinH-index: 0

    CiteScore: 0.30
    WHO Drug InformationH-index: 0

    CiteScore: 0.10
    Cancer and Chemotherapy ReviewsH-index: 0

    CiteScore: 0.10
    Journal fur Pharmakologie und TherapieH-index: 0

    CiteScore: 0.10
    P and TH-index: 0

    CiteScore: 7.60
    學科內最受檢索的期刊 頁面查看次數
    Infection and Drug Resistance76297
    ACS Pharmacology & Translational Science12462
    Therapeutic Advances in Drug Safety9452
    OpenNano4586
    Medicine in Drug Discovery4074
    WHO Drug Information3698
    P and T3512
    Cancer and Chemotherapy Reviews3403
    Drugs and Therapy Perspectives3318
    Journal fur Pharmakologie und Therapie3256
  •  

    npj Breast Cancer npj Breast Cancer
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [npj Breast Cancer] 的評論撰寫評論
作者: tangcy101


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-25 09:13:58 評論於
Peer review
First reviewer(s) invited on 21 Mar 2026

It has been 35 days, and 5 reviewers have not yet accepted the invitation. (When peer reviewers accept the invitation to review your submission, they’ll then start working on a report and providing comments.)
(0) 讚! | tangcy101

作者: 望潇翁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-13 15:20:30 評論於
This is so frustrating, this magazine is so slow. You updated your status over forty days ago, and I've been waiting for almost five months. It has always been "with editor," but when I emailed last month, the assistant editor said they had received the review comments and were waiting for the editorial decision. Now over a month has passed, and they still haven't replied to my emails for over a week. If I had known it would be this slow, I wouldn't have submitted to this magazine. It's just too slow.
(0) 讚! | 望潇翁

作者: 投稿必中


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-05 17:30:48 評論於
Original: 楼主,还有反应吗?还是在邀请审稿人吗?

Translation: OP, any response? Or are you still inviting reviewers?
(0) 讚! | 投稿必中

作者: tangcy101


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-22 09:59:52 評論於
After more than 40 days, we finally started to invite reviewers (5 in total).
(0) 讚! | tangcy101

作者: tangcy101


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-03 10:20:42 評論於
It's been more than 20 days with the editor, and nothing has changed.
(0) 讚! | tangcy101

作者: 云图


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2020-10-13 03:01:34 評論於
Genetic related article. It was submitted in January, and accepted in June. There were 3 reviewers.

(0) 讚! | 云图

作者: 云图


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-10-13 02:59:45 評論於
According to the current forecast, the impact factor can be over 10 in 2021. The review comments are helpful.

(0) 讚! | 云图

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [npj Breast Cancer] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*